Home>Topics>Stocks>Stereotaxis

Stereotaxis STXS

  1. All
  2. Commentary
    1. Dropping Coverage of Stereotaxis

      Commentary

      Tue, 9 Aug 2011

      We are no longer providing equity research on Stereotaxis STXS and we are suspending our star rating at this time. We provide broad coverage of more than 1,700 companies across more than

    2. Partnership Updates for Stereotaxis

      Commentary

      Mon, 24 Jan 2011

      Stereotaxis STXS recently announced some partnership and regulatory updates. The firm ..... next-generation catheter and regulatory submissions in international markets. Stereotaxis also forged a partnership with Siemens SI to sell its Odyssey Cinema

    3. Delays Ahead for Stereotaxis' Systems

      Commentary

      Thu, 14 Oct 2010

      Stereotaxis STXS announced lower-than-expected third-quarter ..... impact on our fair value estimate. Stereotaxis believes revenue will come in around ..... installation delays for this shortfall. Stereotaxis ' imaging partner has experienced production

    4. Solid 2Q for Stereotaxis

      Commentary

      Tue, 3 Aug 2010

      Stereotaxis STXS reported a strong second quarter that came in slightly above our expectations; however, the stock fell, possibly due to management

    5. More System Orders for Stereotaxis

      Commentary

      Tue, 13 Jul 2010

      Stereotaxis STXS pre-announced on Tuesday that it received $10 million in new capital orders for its Niobe system in the second quarter, causing

    6. Sales Dip in Stereotaxis' 1Q

      Commentary

      Thu, 6 May 2010

      Stereotaxis STXS reported first - quarter results that came in below our expectations ..... fewer Niobe placements . The firm recognized revenue on four systems . Stereotaxis 'deferred revenue and backlog did slightly grow , however . Odyssey

    7. Decent 4Q for Stereotaxis

      Commentary

      Thu, 25 Feb 2010

      Stereotaxis STXS reported fourth-quarter results that ..... accounted for the balance of revenue. Stereotaxis recognized 6 Niobe sales and 11 Odyssey ..... over the fourth quarter of 2008. Stereotaxis has invested in hiring salespeople

    8. Uptick in Sales for Hansen in 4Q

      Commentary

      Wed, 24 Feb 2010

      Technologies. We will dig into our system sales and price expectations as we refine our 2010 projections. Close competitor Stereotaxis STXS reports results Thursday, which will give us another indication of how hospital capital spending fared during the

    9. 4Q Preview for Stereotaxis

      Commentary

      Thu, 11 Feb 2010

      Stereotaxis STXS will report fourth-quarter results in two weeks. We predict that ..... to keep these costs below $60 million for the year. In January, Stereotaxis and its partner, Biosense Webster, enhanced their catheter portfolio

    10. Lower Sales Mar Hansen Medical's 3Q

      Commentary

      Tue, 17 Nov 2009

      irrigated catheter in Europe, which will enable more cardiac procedures. We still expect that close competitor Stereotaxis STXS will present a tough challenge, given its longer procedural history and safety record. Yet, given the price differential

    « Prev123Next »
    Content Partners